4.8 Article

An engineered influenza virus to deliver antigens for lung cancer vaccination

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Review Cancer vaccines: Building a bridge over troubled waters

MacLean C. Sellars et al.

Summary: This article reviews the immunologic concepts of cancer vaccines and highlights the challenges they face. Recent technological advances provide new opportunities for studying cancer vaccines, such as neoantigen prediction and genetically engineered models.
Article Biochemistry & Molecular Biology

Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression

Caitlyn L. Miller et al.

Summary: Conjugating an immunostimulant with a tumor-targeted peptide improves the efficacy of systemically administered immunotherapy, transforming the immune-suppressive tumor microenvironment into a lymphocyte-rich environment. Furthermore, this treatment generates tumor-specific CD8(+)T cells.

CELL CHEMICAL BIOLOGY (2022)

Review Oncology

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

Eryn Blass et al.

Summary: Immunotherapy has revolutionized cancer treatment with the development of immune-checkpoint inhibitors and personalized neoantigen vaccines. These vaccines trigger specific T cell responses against individual patient's tumors, showing promising tumor-specific immunogenicity and antitumor activity.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Cell & Tissue Engineering

CAR T cells in solid tumors: challenges and opportunities

Faroogh Marofi et al.

Summary: CAR T cells have shown significant advancements in treating blood disorders, but face challenges in solid tumor therapy due to issues with recognition, trafficking, and survival within the tumor. Efforts to overcome these challenges, including addressing the immunosuppressive tumor microenvironment, show promise in reducing T cell exhaustion and improving therapeutic outcomes in non-hematologic malignancies.

STEM CELL RESEARCH & THERAPY (2021)

Review Oncology

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

Pier Francesco Ferrucci et al.

Summary: Talimogene laherparepvec (T-VEC) is an oncolytic viral immunotherapy approved for the treatment of melanoma, aiming to trigger immune responses locally and potentially synergize with immune checkpoint inhibitors.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Inflammation and tumor progression: signaling pathways and targeted intervention

Huakan Zhao et al.

Summary: Inflammation plays a crucial role in cancer development and therapy, either promoting or inhibiting tumor progression and therapeutic outcomes. Various signaling pathways and factors have been identified as pivotal regulators of inflammation initiation and resolution.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Cell Biology

At the bench: Engineering the next generation of cancer vaccines

Daniel Shae et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Review Chemistry, Multidisciplinary

Peptide-Based Vaccines: Current Progress and Future Challenges

Ryan J. Malonis et al.

CHEMICAL REVIEWS (2020)

Article Multidisciplinary Sciences

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Jenna H. Newman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase

Joanna M. Wandzik et al.

Article Oncology

Neoepitopes-based vaccines: challenges and perspectives

Vincent Alcazer et al.

EUROPEAN JOURNAL OF CANCER (2019)

Review Immunology

Recombinant influenza A viruses as vaccine vectors

Thomas Gerlach et al.

EXPERT REVIEW OF VACCINES (2019)

Review Oncology

The clinical role of the TME in solid cancer

Nicolas A. Giraldo et al.

BRITISH JOURNAL OF CANCER (2019)

Review Oncology

The lung microenvironment: an important regulator of tumour growth and metastasis

Nasser K. Altorki et al.

NATURE REVIEWS CANCER (2019)

Article Medicine, General & Internal

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

Jeffrey C. Kwong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Medicine, General & Internal

Chimeric Antigen Receptor Therapy

Carl H. June et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Oncolytic viruses as engineering platforms for combination immunotherapy

Kwame Twumasi-Boateng et al.

NATURE REVIEWS CANCER (2018)

Review Infectious Diseases

The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection

Subhashini A. Sellers et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)

Review Immunology

The Importance of Dendritic Cells in Maintaining Immune Tolerance

Cindy Audiger et al.

JOURNAL OF IMMUNOLOGY (2017)

Review Oncology

Targeting neoantigens to augment antitumour immunity

Mark Yarchoan et al.

NATURE REVIEWS CANCER (2017)

Article Multidisciplinary Sciences

Generation of influenza A viruses as live but replication-incompetent virus vaccines

Longlong Si et al.

SCIENCE (2016)

Article Medicine, Research & Experimental

Cross-presenting CD103+ dendritic cells are protected from influenza virus infection

Julie Helft et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Immunology

Adoptive immunotherapy for cancer: harnessing the T cell response

Nicholas P. Restifo et al.

NATURE REVIEWS IMMUNOLOGY (2012)